Risk for coronary artery disease in testicular cancer survivors regarding to different treatment modalities
| Author (year) | N | Period of treatment | Median follow up (range), in years | Age at diagnosis (range) | Age at follow-up (range) | Risk for CAD (CI 95 %) | Treatment Modalities | Note |
|---|---|---|---|---|---|---|---|---|
| Meinardi et al.17 (2000) | 87 | Before 1987 All patients treated with cisplatin based chemotherapy before 1987. | 14 (10 to 20) | 27 (17-36) | 42 (30-50) | SIR=7.1 (1.9 to 18.3) | ChT | Age adjusted results. Older than 50 |
| Huddart et al.24 (2003) | 992 | 1982-1992 | 10.2 (0 to 20.3) | 31.7 (10-82) | 44 (23-78) | RR=1.00 (reference) | Surveillance | Age adjusted results. Only 8.3 % |
| Van der Belt- | 2339 | 1965-1995 | 18.4 (5 to 38.4) | 38.3 Age for seminoma patients. Age for nonseminoma patients. | 59.8 Age for seminoma patients. Age for nonseminoma patients. | SIR=0.94 (0.61 to 1.39) | Surveillance | Patients with CAD before or |
| Haughnes et al.12 (2010) | 990 | 1980-1994 | 19 (13 to 28) | 31 (15-53) | 51 (31-69) | HR=1.0 (reference) | Surveillance | Age adjusted results. Patients with |